Xintao Qiu

4.8k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

Xintao Qiu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xintao Qiu has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Xintao Qiu's work include Genomics and Chromatin Dynamics (4 papers), Prostate Cancer Treatment and Research (4 papers) and RNA modifications and cancer (3 papers). Xintao Qiu is often cited by papers focused on Genomics and Chromatin Dynamics (4 papers), Prostate Cancer Treatment and Research (4 papers) and RNA modifications and cancer (3 papers). Xintao Qiu collaborates with scholars based in United States, China and Czechia. Xintao Qiu's co-authors include Henry W. Long, Myles Brown, X. Shirley Liu, Prakash K. Rao, Klothilda Lim, John G. Doench, Aya Kobayashi, Rong En Tay, Adrienne Luoma and Deng Pan and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Xintao Qiu

24 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

2018 567 citations Deng Pan, Aya Kobayashi et al. Science profile →

Peers

Countries citing papers authored by Xintao Qiu

Since Specialization

Citations

This map shows the geographic impact of Xintao Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xintao Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xintao Qiu more than expected).

Fields of papers citing papers by Xintao Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xintao Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xintao Qiu. The network helps show where Xintao Qiu may publish in the future.

Co-authorship network of co-authors of Xintao Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xintao Qiu. A scholar is included among the top collaborators of Xintao Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xintao Qiu. Xintao Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lectin-affinity glycosylation pattern analysis of plasma extracellular vesicles: An all-in-one clinical assessment for gastric cancer diagnosis and treatment 2025 ·Cancer Letters ·Fanqin Bu, Guangyu Ding, Lin Yang, (unknown), Chenjie Xu, (unknown), Ruixuan Chen, Lan Sun, Xintao Qiu, Pengfei Yu, Jingxin Meng, Meng Fan, Yibin Xie, Min Li	1
2	Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer 2025 ·Cancer Discovery ·Nitin H. Shirole, (unknown), Yenarae Lee, Amy Goodale, Sudeepa Syamala, Shweta Kukreja, Rong Li, Xintao Qiu, Wenyu Yu, Seth Goldman, Paloma Cejas, Henry W. Long, Karen Adelman, John G. Doench, William R. Sellers, William G. Kaelin	2
3	Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2 2025 ·ESMO Open ·Xintao Qiu, (unknown), Rong Li, Albert Grinshpun, Hersh Gupta, Melissa E. Hughes, Gregory J. Kirkner, (unknown), Bruce E. Johnson, (unknown), Andrew D. Cherniack, Ying Jiang, Ning Zhou, Nancy U. Lin, Huan Long, Sara M. Tolaney, Rinath Jeselsohn	0
4	Cancer–stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies 2024 ·Proceedings of the National Academy of Sciences ·Marie-Anne Goyette, Laura E. Stevens, (unknown), Marco Seehawer, Jun Nishida, Zheqi Li, (unknown), Rong Li, Xintao Qiu, (unknown), Stephanie Zhao, Klothilda Lim, Gabrielle S. Tender, Jason J. Northey, Nicholas M. Riley, Henry W. Long, Carolyn R. Bertozzi, Valerie M. Weaver, Kornélia Polyák	15
5	Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer 2024 ·Cell Reports ·(unknown), Mannan Nouri, Jiaqian Liang, Shaoyong Chen, Andreas Varkaris, (unknown), Olga Voznesensky, Irene Lee, Xintao Qiu, Laura Cato, Ji-Heui Seo, Matthew L. Freedman, Adam G. Sowalsky, Nathan A. Lack, Eva Corey, Peter S. Nelson, Myles Brown, Henry W. Long, Joshua W. Russo, Steven P. Balk	4
6	Learnable Global Spatio-Temporal Adaptive Aggregation for Bracketing Image Restoration and Enhancement 2024 ·(unknown), Yuanbo Zhou, Xintao Qiu, Hui Tang, Wei Deng, (unknown), (unknown)	1
7	Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer 2023 ·Molecular Cancer Therapeutics ·Maša Alečković, Zheqi Li, (unknown), Xintao Qiu, (unknown), Pierre Foidart, (unknown), (unknown), Shaokun Shu, Nikolas Kesten, Rong Li, Klothilda Lim, Ana C. Garrido-Castro, Jennifer L. Guerriero, Jun Qi, Henry W. Long, Kornélia Polyák	6
8	Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA 2023 ·Nature Protocols ·Lin Yang, (unknown), Jennifer Altreuter, Aashna Jhaveri, (unknown), Li Song, Jingxin Fu, Len Taing, (unknown), Avinash Sahu, Collin Tokheim, Yi Zhang, Zexian Zeng, (unknown), Ming Tang, Xintao Qiu, Henry W. Long, Franziska Michor, (unknown), X. Shirley Liu	12
9	Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome 2022 ·JCI Insight ·Xintao Qiu, Lisha G. Brown, (unknown), Holly M. Nguyen, Nadia Boufaied, Sarah Abou Alaiwi, Ji-Heui Seo, Talal El Zarif, Connor Bell, Edward O’Connor, Brian Hanratty, Mark M. Pomerantz, Matthew L. Freedman, Myles Brown, Michael C. Haffner, Peter S. Nelson, Felix Y. Feng, David P. Labbé, Henry W. Long, Eva Corey	15
10	Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer 2022 ·Clinical Epigenetics ·Tesa Severson, Xintao Qiu, Mohammed Alshalalfa, Martin Sjöström, David A. Quigley, Andries M. Bergman, Henry W. Long, Felix Y. Feng, Matthew L. Freedman, Wilbert Zwart, Mark M. Pomerantz	13
11	CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis 2021 ·Genomics Proteomics & Bioinformatics ·Xintao Qiu, Avery Feit, Ariel Feiglin, Yingtian Xie, Nikolas Kesten, Len Taing, (unknown), Shengqing Gu, Yihao Li, (unknown), (unknown), Rinath Jeselsohn, Myles Brown, X. Shirley Liu, Henry W. Long	16
12	Integrative analyses of single-cell transcriptome and regulome using MAESTRO 2020 ·Genome biology ·Chenfei Wang, Dongqing Sun, Xin Huang, Changxin Wan, Ziyi Li, Ya Han, Qian Qin, Jing‐Yu Fan, Xintao Qiu, Yingtian Xie, Clifford A. Meyer, Myles Brown, Ming Tang, Henry W. Long, Tao Liu, X. Shirley Liu	122
13	A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing breakdown → 2018 ·Science ·Deng Pan, Aya Kobayashi, Peng Jiang, Lucas Ferrari de Andrade, Rong En Tay, Adrienne Luoma, Daphne Tsoucas, Xintao Qiu, Klothilda Lim, Prakash K. Rao, Henry W. Long, Guo‐Cheng Yuan, John G. Doench, Myles Brown, X. Shirley Liu, Kai W. Wucherpfennig	567
14	VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis 2018 ·BMC Bioinformatics ·MacIntosh Cornwell, Mahesh Vangala, Len Taing, Zachary T. Herbert, Johannes Köster, Bo Li, Hanfei Sun, Taiwen Li, Jian Zhang, Xintao Qiu, Matthew Pun, Rinath Jeselsohn, Myles Brown, X. Shirley Liu, Henry W. Long	109
15	A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer 2018 ·Cell ·David Y. Takeda, Sándor Spisák, Ji-Heui Seo, Connor Bell, Edward O’Connor, Keegan Korthauer, Dezső Ribli, István Csabai, Norbert Solymosi, Zoltán Szállási, (unknown), Paloma Cejas, Xintao Qiu, Henry W. Long, Viktória Tisza, Pier Vitale Nuzzo, Mersedeh Rohanizadegan, Mark M. Pomerantz, William C. Hahn, Matthew L. Freedman	202
16	Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer 2018 ·International Journal of Oncology ·Bin Cao, Yu Zhao, Zheng Zhang, Hengcun Li, (unknown), Shuilong Guo, Xintao Qiu, Shutian Zhang, Li Min, Shengtao Zhu	12
17	Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes 2016 ·Translational Oncology ·Li Min, Yu Zhao, Shengtao Zhu, Xintao Qiu, Rui Cheng, (unknown), (unknown), Shuilong Guo, Shutian Zhang	24
18	Robustness evaluation of corner detectors for use in ultrasound image processing 2013 ·(unknown), (unknown), (unknown), Xintao Qiu	3
19	A novel approach to optimize the objective function based on VC dimension and structural risk minimization 2011 ·Chinese Control Conference ·Xintao Qiu, Dongmei Fu, Tao Yang	2
20	The method for material corrosion modelling and feature selection with SVM-RFE 2011 ·Xintao Qiu, Dongmei Fu, (unknown), Kamil Říha, Radim Bürget	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact